Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington's disease. (full – 2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2931573/?toolubmed
Learning and memory performances in adolescent users of alcohol and marijuana: interactive effects. (full – 2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2965487/
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis. (full – 2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2931570/?toolubmed
The Neuroprotective Effect of Cannabinoid Receptor Agonist (WIN55,212-2) in Paraoxon Induced Neurotoxicity in PC12 Cells and N-methyl-D-aspartate Receptor Interaction (full – 2010) http/celljournal.org/library/upload/article/af_4334422Hashemi.pdf
THC Prevents MDMA Neurotoxicity in Mice. (full – 2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2824821/
The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxicischemic brain damage in mice is mediated by CB(2) and adenosine receptors. (abst – 2010) http/www.ncbi.nlm.nih.gov/pubmed/19900555
Cannabinoid receptor agonist protects cultured dopaminergic neurons from the death by the proteasomal dysfunction. (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3145842/?toolubmed
Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ (full – 2011) http/onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01444.x/full
N-arachidonoyl--serine is neuroprotective after traumatic brain injury by reducing apoptosis (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3170948/
Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation. (full – 2011) http/www.jimmunol.org/content/187/12/6508.full?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults. (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3158793/
HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions. (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3098312/
Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults. (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3052737/pdf/nihms266962.pdf
Cannabinoid-containing plant extracts as neuroprotective agents – Patent EP2332533 (A1) ― 2011-06-15 (full – 2011) http/worldwide.espacenet.com/publicationDetails/description?CC=EP&NR=2332533A1&KC=A1&FT&ND=3&date=20110615&DB=EPODOC&locale=en_EP
Cannabinoids and Innate Immunity: Taking a Toll on Neuroinflammation (link to PDF – 2011) http/www.tswj.com/2011/230786/abs/
Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine. (abst – 2011) http/www.ncbi.nlm.nih.gov/pubmed/20980074
Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis. (abst – 2011) http/www.ncbi.nlm.nih.gov/pubmed/21850403
New metabolic pathway for controlling brain inflammation (news – 2011) http/www.news-medical.net/news/20111021/New-metabolic-pathway-for-controlling-braininflammation.aspx
Learning and memory performances in adolescent users of alcohol and marijuana: interactive effects. (full – 2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2965487/
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis. (full – 2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2931570/?toolubmed
The Neuroprotective Effect of Cannabinoid Receptor Agonist (WIN55,212-2) in Paraoxon Induced Neurotoxicity in PC12 Cells and N-methyl-D-aspartate Receptor Interaction (full – 2010) http/celljournal.org/library/upload/article/af_4334422Hashemi.pdf
THC Prevents MDMA Neurotoxicity in Mice. (full – 2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2824821/
The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxicischemic brain damage in mice is mediated by CB(2) and adenosine receptors. (abst – 2010) http/www.ncbi.nlm.nih.gov/pubmed/19900555
Cannabinoid receptor agonist protects cultured dopaminergic neurons from the death by the proteasomal dysfunction. (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3145842/?toolubmed
Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ (full – 2011) http/onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01444.x/full
N-arachidonoyl--serine is neuroprotective after traumatic brain injury by reducing apoptosis (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3170948/
Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation. (full – 2011) http/www.jimmunol.org/content/187/12/6508.full?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults. (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3158793/
HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions. (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3098312/
Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults. (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3052737/pdf/nihms266962.pdf
Cannabinoid-containing plant extracts as neuroprotective agents – Patent EP2332533 (A1) ― 2011-06-15 (full – 2011) http/worldwide.espacenet.com/publicationDetails/description?CC=EP&NR=2332533A1&KC=A1&FT&ND=3&date=20110615&DB=EPODOC&locale=en_EP
Cannabinoids and Innate Immunity: Taking a Toll on Neuroinflammation (link to PDF – 2011) http/www.tswj.com/2011/230786/abs/
Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine. (abst – 2011) http/www.ncbi.nlm.nih.gov/pubmed/20980074
Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis. (abst – 2011) http/www.ncbi.nlm.nih.gov/pubmed/21850403
New metabolic pathway for controlling brain inflammation (news – 2011) http/www.news-medical.net/news/20111021/New-metabolic-pathway-for-controlling-braininflammation.aspx